Brandon May

Brandon May is a freelance medical writer and owner of May Medical Communications, LLC. He holds a BS in Nutrition and Dietetics from the University of Houston. Throughout his career, he has written over 700 medical news articles across several different therapeutic areas. In addition to covering the medical news, Brandon also creates content for continuing medical education providers, hospitals, and pharmaceutical and medical device companies across the globe.

All articles by Brandon May

Stroke

Stroke-Associated Pneumonia: Risk Factors, Mechanisms, and Interventions

Brandon May

May 20, 2022

Stroke-associated pneumonia research over the past 2 decades has yielded significant insight into SAP risk factors, diagnostic measures, and management strategies.

AAN 2022

β2-Adrenoreceptor Medications Associated With Lower Risk for Parkinson Disease

Brandon May

April 4, 2022

Presenting at the 2022 AAN Annual Meeting, researchers explored the association between β2-adrenoreceptor agonists and the risk for Parkinson disease.

AAN 2022

Ganaxolone: A Treatment for Major Motor Seizures in CDKL5 Deficiency Disorder

Brandon May

April 4, 2022

In a global, phase 3 trial, researchers evaluated the efficacy of ganaxolone as an adjunctive treatment compared to placebo for major motor seizures in patients with CDKL5 deficiency disorder.

AAN 2022

GBA Variants Impact Cognitive Status in Amyotrophic Lateral Sclerosis

Brandon May

April 4, 2022

Researchers sought to determine the effect GBA variants have on cognitive status in patients with amyotrophic lateral sclerosis.

AAN 2022

Parkinson Disease Psychosis Tied to Higher Risk for All-Cause Mortality

Brandon May

April 4, 2022

Presenting at the 2022 AAN Annual Meeting, Mayo Clinic researchers investigated and compared the survival rates and symptoms of Parkinson disease and Parkinson disease psychosis.

Patients with nerve damage often experience muscle weakness that may make it harder to maintain balance. Physical therapy and assistive devices, such as braces, canes and walkers, can be helpful for preventing falls.

AAN 2022

Natalizumab Efficacy of 4- to 6-Week Dosing Schedule Switch in Multiple Sclerosis

Brandon May

April 4, 2022

Researchers assessed the efficacy of a natalizumab 6-week dosing schedule in patients with multiple sclerosis who received natalizumab 4-week dosing without relapse for 12 or more months.

AAN 2022

Low LDL Cholesterol Levels Tied to Stroke Severity in Intracerebral Hemorrhage

Brandon May

April 4, 2022

Presenting at the 2022 AAN Annual Meeting, the researchers hypothesized that low LDL levels may be linked to severe ICH at presentation and worse outcomes.

Multiple Sclerosis

Neuroimaging in Multiple Sclerosis: Predicting Longitudinal Disability and Cognition

Brandon May

January 25, 2022

In a systematic review and meta-analysis of longitudinal studies, researchers used neuroimaging for its predictive ability to determine cognitive decline and disability outcomes in MS.

Neuromuscular Disorders

Amyotrophic Lateral Sclerosis Cognitive Profiles: Levels of Insight Into Behavioral Changes

Brandon May

January 24, 2022

Researchers sought to assess the loss of insight related to behavioral changes across cognitive profiles in amyotrophic lateral sclerosis subgroups.

Vascular Neurology

High Blood Pressure, BMI Tied to Greater Burden of Cerebral Small Vessel Disease

Brandon May

January 24, 2022

Using Mendelian randomization, researchers investigated which cardiovascular risk factors are likely to be implicated in the etiology of cerebral small vessel disease.

Next post in Vascular Neurology